Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-25

Clinical Trial Update: A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing linvoseltamab to standard treatment in adults with multiple myeloma who are not transplant-eligible to evaluate safety and effi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linvoseltamab

Snippet

Sponsor: European Myeloma Network B.V. | Conditions: Multiple Myeloma | Phase 3 | Status: RECRUITING